AI-analyzed blood test can predict the progression of neurodegenerative disease
The Neuro - Montreal Neurological Institute and HospitalEvaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.